Clinical Trials Browser

Phase 2 × Not yet recruiting × relugolix × Clear all

NCT07455903 2026-03-06

Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT

Phase 2 Not yet recruiting

Prostatic Neoplasms

NCT06129851 2023-11-13

Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer

Phase 2 Not yet recruiting

Prostatic Neoplasms